Fully closed cell sorter for immune cell therapy manufacturing

Bibliographic Details
Title: Fully closed cell sorter for immune cell therapy manufacturing
Authors: Masahiro Matsumoto, Shinji Tashiro, Tatsumi Ito, Kazuya Takahashi, Gakuji Hashimoto, Junji Kajihara, Yoshihiro Miyahara, Hiroshi Shiku, Yoichi Katsumoto
Source: Molecular Therapy: Methods & Clinical Development, Vol 30, Iss , Pp 367-376 (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Genetics
LCC:Cytology
Subject Terms: cell therapy manufacturing, cell sorting, cell purification, functional assay, cGMP, cell therapy, Genetics, QH426-470, Cytology, QH573-671
More Details: By analyzing patients treated with adoptive immune cell therapies, various immune cell phenotypes have been found in the starting and infused materials as determinants of sustained remission. The isolation of these specific phenotypes for clinical use requires current Good Manufacturing Practice (cGMP)-compliant cell-sorting technologies with multiparameter selection capabilities. Here, we developed a cGMP-requirement-applicable fully closed cell sorter that has a suction mechanism and multiparameter detection using two laser optical settings. Negative pressure generated by a change in the chamber volume at a sorting point allows the isolation of cells of interest with high viability and purity. Our study demonstrated that this microfluidic sorter enables the isolation of cells of interest at an effective rate of 7,000 sorts per second on average. A purity of 85.5% and 77.1% effective yield with 93.7% viability was obtained when applying a target population of 35.9% in total (lymphocyte+CD8+) at 15,000 events per second (2 × 107 cells/mL). The sorted gene-modified T cells maintain largely unaltered proliferation, antigen recognition, cytokine release, and cytotoxicity functionalities.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2329-0501
Relation: http://www.sciencedirect.com/science/article/pii/S2329050123001146; https://doaj.org/toc/2329-0501
DOI: 10.1016/j.omtm.2023.07.012
Access URL: https://doaj.org/article/2519a81bb32f4c479886bbd35c498d85
Accession Number: edsdoj.2519a81bb32f4c479886bbd35c498d85
Database: Directory of Open Access Journals
More Details
ISSN:23290501
DOI:10.1016/j.omtm.2023.07.012
Published in:Molecular Therapy: Methods & Clinical Development
Language:English